CSCs have been identified in many solid tumors, including breast [17], lung [18], colon [19], prostate [20], ovary [21], brain cancer [22], and sarcoma [23]; in H&N cancer, the existence of CSCs was first assessed using CD44 as a stem cell marker [24]. The gene discussed is CD44; the disease is cancer.